What is the recommended acute management for a patient with a wake‑up stroke (suspected acute ischemic stroke with unknown onset time)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Wake-Up Stroke Management

For patients with wake-up stroke (acute ischemic stroke with unknown onset time), administer IV thrombolysis if they are within 4.5 hours of symptom recognition and MRI shows DWI-FLAIR mismatch (DWI lesion <1/3 MCA territory with no marked FLAIR hyperintensity), or use CT/MR perfusion imaging to identify salvageable penumbra for treatment up to 9-24 hours from last known well. 1

Imaging-Based Treatment Algorithm

Within 4.5 Hours of Symptom Recognition (When Patient Awakens)

MRI-Based Selection (WAKE-UP Protocol):

  • Obtain emergent MRI with DWI and FLAIR sequences 1
  • Treat with IV thrombolysis if:
    • DWI lesion is present but smaller than one-third of MCA territory
    • No marked (clearly visible) FLAIR hyperintensity in the same region as DWI lesion
    • Subtle FLAIR changes are acceptable (signal intensity ratio <1.2 between affected and mirror regions) 1
    • This approach achieved 53.3% excellent outcomes (mRS 0-1) versus 41.8% with placebo 1

This MRI mismatch paradigm identifies patients whose biological stroke onset is likely within 4.5 hours, even though clock time is unknown. The WAKE-UP trial demonstrated clear benefit with this selection method 1, 2, 3.

Beyond 4.5 Hours from Last Known Well (4.5-24 Hour Window)

Perfusion-Based Selection:

For 4.5-9 hour window:

  • Obtain CT perfusion or MR DWI-PWI with automated postprocessing 1
  • Treat if salvageable ischemic penumbra is present
  • The EXTEND trial showed 35.4% versus 29.5% excellent outcomes (adjusted RR 1.44) despite increased symptomatic ICH risk (6.2% vs 0.9%) 1

For 4.5-24 hour window with large vessel occlusion:

  • If patient cannot receive endovascular thrombectomy but has salvageable penumbra on perfusion imaging
  • IV thrombolysis may be beneficial when administered by stroke experts 1
  • This represents a Class 2b recommendation (lower certainty but potential benefit)

Safety Profile

Symptomatic intracranial hemorrhage risk: 3% with thrombolysis versus 1% with control in wake-up stroke patients 3. Meta-analysis of extended window trials confirmed increased sICH risk (adjusted OR 9.7) but overall benefit in functional outcomes (adjusted OR 1.86 for mRS 0-1) 1.

Mortality: No significant difference at 90 days (4.0% thrombolysis vs 1.9% control, p=0.162 in wake-up cohorts) 4, 3.

Critical Implementation Points

  • Imaging must be performed rapidly (target <25 minutes) to facilitate timely treatment 1
  • Do not delay vascular imaging (CTA/CTP) to obtain serum creatinine 1
  • Wake-up stroke patients show similar clinical and imaging characteristics to known-onset strokes, suggesting ictus occurs just before awakening 5
  • Approximately 25% of all acute ischemic strokes are wake-up strokes 6
  • Over 80% of surveyed hospitals now follow standardized institutional protocols for wake-up stroke 6

Endovascular Thrombectomy Consideration

For wake-up strokes with large vessel occlusion:

  • Emergent brain and vascular imaging (CT/CTA or MRI/MRA) should be performed immediately 1
  • In the 6-24 hour window, use adjunctive perfusion imaging for EVT selection 1
  • EVT in selected wake-up stroke patients with LVO achieved 46% excellent outcomes versus 9% with control (RR 5.12) 3

Common Pitfalls to Avoid

  • Do not automatically exclude wake-up stroke patients from thrombolysis based solely on unknown time—use imaging selection criteria
  • Subtle FLAIR changes are acceptable in the WAKE-UP paradigm; only marked/clearly visible FLAIR hyperintensity is exclusionary 1
  • Do not delay imaging for laboratory results when considering advanced imaging with contrast 1
  • Recognize that non-wake-up unwitnessed strokes may have similar treatment effects, though evidence is less robust due to smaller sample sizes 4

The paradigm shift from strict time-based to tissue-based selection has substantially expanded treatment eligibility for wake-up stroke patients, with high-certainty evidence supporting both MRI-based and perfusion-based selection strategies 1, 2, 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.